Publication | Open Access
Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension
138
Citations
14
References
2022
Year
These results support the longer-term safety and durability of clinical benefit of sotatercept for pulmonary arterial hypertension.
| Year | Citations | |
|---|---|---|
Page 1
Page 1